BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $984K invested in ProShares UltraShort NASDAQ Biotechnology in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more capital invested

Capital invested by funds: $ → $

less call options, than puts

Call options by funds: $ | Put options by funds: $

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8K
Puts
$10K
Net Calls
Net Calls Change

Top Buyers

1
+$139K
2
+$6K

Top Sellers

1
-$52.8K
2
-$47.1K
3
-$23K
4
Morgan Stanley
Morgan Stanley
New York
-$625
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$424K
2
$354K
3
$173K
4
$22.7K
5
$6K
6
$2.52K
7
$1.77K
8
$1.04K